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Biology

In vitro Screening for Modulators
of Synaptic Development in a Model
of Fragile X Syndrome
Kelsey Barter
Mentor: Aaron DiAntonio
Fragile X Syndrome (FXS) is the most common genetic cause of intellectual disability,
caused by an X-linked mutation in the gene Fmr1, which encodes for Fragile X Mental
Retardation Protein (FMRP). FMRP is essential for normal cognitive development
and function, and across species, mutations in Fmr1 drive mutant phenotypes at the
synapse. Accordingly, the function of FMRP is highly conserved across species; FMRP
is a translational repressor with over 800 mRNA targets identified in the mouse. In
the absence of FMRP, loss of translational repression over target mRNAs results in
overexpression of the respective protein products. In mammals, there are obvious and
functionally relevant defects in the development of dendritic spines, which are the
sites at which a neuron receives excitatory synaptic input from other neurons. Cortical
neurons of Fmr1-knockout (KO) mice, a well-established mammalian model of FXS,
have immature, thin dendritic spines. A virtually identical malformation of dendritic
spines has been observed in the brains of humans who had FXS, indicating that proper
spine development is a conserved and critical aspect of FMRP function. This phenotype
also affects synaptic function; cortical neurons from Fmr1-KO mice are hyperexcitable.
We developed an assay to culture Fmr1-KO mouse embryonic cortical neurons to screen
for genetic and pharmacological manipulations that can reverse these defects. The goal is
to discover novel genes and proteins that, when knocked down or inhibited, reverse the
in vitro immature spine phenotype of Fmr1-KO neurons, suggesting they are normally
targeted by FMRP. We hypothesize that overexpression of these key targets may drive
Fmr1-KO mutant phenotypes at the synapse. FXS is a developmental and intellectual
disorder of entirely genetic origin; because it is frequently linked and shares similarities
to Autism Spectrum Disorders (ASD), a hit from our screen could have therapeutic
potential for the larger class of disorders.
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